Cargando…

Epigenetics, heritability and longitudinal analysis

BACKGROUND: Longitudinal data and repeated measurements in epigenome-wide association studies (EWAS) provide a rich resource for understanding epigenetics. We summarize 7 analytical approaches to the GAW20 data sets that addressed challenges and potential applications of phenotypic and epigenetic da...

Descripción completa

Detalles Bibliográficos
Autores principales: Nustad, Haakon E., Almeida, Marcio, Canty, Angelo J., LeBlanc, Marissa, Page, Christian M., Melton, Phillip E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156830/
https://www.ncbi.nlm.nih.gov/pubmed/30255778
http://dx.doi.org/10.1186/s12863-018-0648-1
_version_ 1783358165311553536
author Nustad, Haakon E.
Almeida, Marcio
Canty, Angelo J.
LeBlanc, Marissa
Page, Christian M.
Melton, Phillip E.
author_facet Nustad, Haakon E.
Almeida, Marcio
Canty, Angelo J.
LeBlanc, Marissa
Page, Christian M.
Melton, Phillip E.
author_sort Nustad, Haakon E.
collection PubMed
description BACKGROUND: Longitudinal data and repeated measurements in epigenome-wide association studies (EWAS) provide a rich resource for understanding epigenetics. We summarize 7 analytical approaches to the GAW20 data sets that addressed challenges and potential applications of phenotypic and epigenetic data. All contributions used the GAW20 real data set and employed either linear mixed effect (LME) models or marginal models through generalized estimating equations (GEE). These contributions were subdivided into 3 categories: (a) quality control (QC) methods for DNA methylation data; (b) heritability estimates pretreatment and posttreatment with fenofibrate; and (c) impact of drug response pretreatment and posttreatment with fenofibrate on DNA methylation and blood lipids. RESULTS: Two contributions addressed QC and identified large statistical differences with pretreatment and posttreatment DNA methylation, possibly a result of batch effects. Two contributions compared epigenome-wide heritability estimates pretreatment and posttreatment, with one employing a Bayesian LME and the other using a variance-component LME. Density curves comparing these studies indicated these heritability estimates were similar. Another contribution used a variance-component LME to depict the proportion of heritability resulting from a genetic and shared environment. By including environmental exposures as random effects, the authors found heritability estimates became more stable but not significantly different. Two contributions investigated treatment response. One estimated drug-associated methylation effects on triglyceride levels as the response, and identified 11 significant cytosine-phosphate-guanine (CpG) sites with or without adjusting for high-density lipoprotein. The second contribution performed weighted gene coexpression network analysis and identified 6 significant modules of at least 30 CpG sites, including 3 modules with topological differences pretreatment and posttreatment. CONCLUSIONS: Four conclusions from this GAW20 working group are: (a) QC measures are an important consideration for EWAS studies that are investigating multiple time points or repeated measurements; (b) application of heritability estimates between time points for individual CpG sites is a useful QC measure for DNA methylation studies; (c) drug intervention demonstrated strong epigenome-wide DNA methylation patterns across the 2 time points; and (d) new statistical methods are required to account for the environmental contributions of DNA methylation across time. These contributions demonstrate numerous opportunities exist for the analysis of longitudinal data in future epigenetic studies.
format Online
Article
Text
id pubmed-6156830
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61568302018-09-27 Epigenetics, heritability and longitudinal analysis Nustad, Haakon E. Almeida, Marcio Canty, Angelo J. LeBlanc, Marissa Page, Christian M. Melton, Phillip E. BMC Genet Methodology BACKGROUND: Longitudinal data and repeated measurements in epigenome-wide association studies (EWAS) provide a rich resource for understanding epigenetics. We summarize 7 analytical approaches to the GAW20 data sets that addressed challenges and potential applications of phenotypic and epigenetic data. All contributions used the GAW20 real data set and employed either linear mixed effect (LME) models or marginal models through generalized estimating equations (GEE). These contributions were subdivided into 3 categories: (a) quality control (QC) methods for DNA methylation data; (b) heritability estimates pretreatment and posttreatment with fenofibrate; and (c) impact of drug response pretreatment and posttreatment with fenofibrate on DNA methylation and blood lipids. RESULTS: Two contributions addressed QC and identified large statistical differences with pretreatment and posttreatment DNA methylation, possibly a result of batch effects. Two contributions compared epigenome-wide heritability estimates pretreatment and posttreatment, with one employing a Bayesian LME and the other using a variance-component LME. Density curves comparing these studies indicated these heritability estimates were similar. Another contribution used a variance-component LME to depict the proportion of heritability resulting from a genetic and shared environment. By including environmental exposures as random effects, the authors found heritability estimates became more stable but not significantly different. Two contributions investigated treatment response. One estimated drug-associated methylation effects on triglyceride levels as the response, and identified 11 significant cytosine-phosphate-guanine (CpG) sites with or without adjusting for high-density lipoprotein. The second contribution performed weighted gene coexpression network analysis and identified 6 significant modules of at least 30 CpG sites, including 3 modules with topological differences pretreatment and posttreatment. CONCLUSIONS: Four conclusions from this GAW20 working group are: (a) QC measures are an important consideration for EWAS studies that are investigating multiple time points or repeated measurements; (b) application of heritability estimates between time points for individual CpG sites is a useful QC measure for DNA methylation studies; (c) drug intervention demonstrated strong epigenome-wide DNA methylation patterns across the 2 time points; and (d) new statistical methods are required to account for the environmental contributions of DNA methylation across time. These contributions demonstrate numerous opportunities exist for the analysis of longitudinal data in future epigenetic studies. BioMed Central 2018-09-17 /pmc/articles/PMC6156830/ /pubmed/30255778 http://dx.doi.org/10.1186/s12863-018-0648-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology
Nustad, Haakon E.
Almeida, Marcio
Canty, Angelo J.
LeBlanc, Marissa
Page, Christian M.
Melton, Phillip E.
Epigenetics, heritability and longitudinal analysis
title Epigenetics, heritability and longitudinal analysis
title_full Epigenetics, heritability and longitudinal analysis
title_fullStr Epigenetics, heritability and longitudinal analysis
title_full_unstemmed Epigenetics, heritability and longitudinal analysis
title_short Epigenetics, heritability and longitudinal analysis
title_sort epigenetics, heritability and longitudinal analysis
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156830/
https://www.ncbi.nlm.nih.gov/pubmed/30255778
http://dx.doi.org/10.1186/s12863-018-0648-1
work_keys_str_mv AT nustadhaakone epigeneticsheritabilityandlongitudinalanalysis
AT almeidamarcio epigeneticsheritabilityandlongitudinalanalysis
AT cantyangeloj epigeneticsheritabilityandlongitudinalanalysis
AT leblancmarissa epigeneticsheritabilityandlongitudinalanalysis
AT pagechristianm epigeneticsheritabilityandlongitudinalanalysis
AT meltonphillipe epigeneticsheritabilityandlongitudinalanalysis